Trial Profile
The impact of chronic viral hepatitis on patient discontinuation of treatment for latent TB [tuberculosis] infection due to hepatotoxicity in USPHS/TBTC study 26
Status:
Not stated
Phase of Trial:
Phase III
Latest Information Update: 05 Dec 2005
Price :
$35
*
At a glance
- Drugs Rifapentine (Primary) ; Isoniazid
- Indications Tuberculosis
- Focus Therapeutic Use
- 05 Dec 2005 New trial record.